Navigation Links
Replidyne Terminates Faropenem Agreements
Date:6/23/2008

hnology."

At May 31, 2008 Replidyne had cash and short term investments totaling $71.5 million.

About Replidyne, Inc.

Replidyne is a biopharmaceutical company focused on discovering, developing, in-licensing and commercializing innovative anti-infective products. Replidyne's lead program is an investigational antibacterial agent REP3123 that targets Gram-positive Clostridium difficile (C. difficile) bacteria and C. difficile Infection (CDI). Replidyne is pursuing the development of other novel anti-infective programs based on its DNA replication inhibition technology and its in-house discovery research.

Safe Harbor

This press release contains plans, intentions, objectives, estimates and expectations that constitute forward-looking statements about Replidyne, Inc. that involve significant risks and uncertainties. Actual results could differ materially from those discussed due to a number of factors including, the success and timing of pre-clinical studies and clinical trials; the Company's ability to obtain and maintain regulatory approval of product candidates and the labeling under any approval that may be obtained; plans to develop and commercialize product candidates; the loss of key scientific or management personnel; the size and growth of the potential markets for the Company's product candidates and the Company's ability to serve those markets; regulatory developments in the U.S. and foreign countries; the rate and degree of market acceptance of any future products; the accuracy of Company estimates regarding expenses, future revenues and capital requirements; the Company's ability to obtain and maintain intellectual property protection for our product candidates; the successful development of the Company's sales and marketing capabilities; the success of competing drugs that are or become available; and the performance of third party manufacturers. These and additional risks and uncertainties are described more fully in the
'/>"/>

SOURCE Replidyne, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Replidyne to Report First Quarter 2008 Earnings
2. Replidyne Announces 2007 Fourth Quarter and Full Year Results
3. Replidyne to Report 2007 Fourth Quarter and Year-End Earnings
4. Replidyne to Announce Third Quarter 2007 Earnings
5. CSL Behring Signs Agreements With Canadian Blood Services and Hema-Quebec to Supply Life-Saving Therapies
6. Raptor Pharmaceuticals Corp. Enters Agreements to Advance Clinical Pipeline
7. Wyeth Pharmaceuticals Ends Collaboration Agreements with Solvay Pharmaceuticals for Bifeprunox and Other Compounds
8. Microfluidic Systems Announces Agreements With Applied Biosystems and United Technologies Hamilton Sundstrand Division for Production of Bioagent Autonomous Networked Detector System
9. Novavax Enters Into Estrasorb(R) Asset Sale and Supply Agreements with Graceway Pharmaceuticals, LLC
10. Vermillion and Johns Hopkins Sign Collaborative Research and License Agreements to Develop Molecular Diagnostic Tests
11. Energy Conversion Devices and United Solar Ovonic Enter Into New $55 Million Secured Credit Facility Agreements
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... , Sept. 23, 2014 ... of the biomaterial family and are increasingly becoming ... body fluids and tissues without having a negative ... used as tissue replacement and tissue repair materials ... materials such as ceramics, glass, glass-ceramics, and composites. ...
(Date:9/23/2014)... Kamal Rashid , PhD, director of ... Center (BETC) and research professor of biology and biotechnology ... an international two-day event focused on biomanufacturing set for ... the event will bring together leaders of companies from ... and produce human therapeutics. “The growth curve for biomanufacturing ...
(Date:9/23/2014)... 2014 This is a professional ... the Phenolic Resin industry in Global and China.The ... including definitions, applications and industry chain structure. Global ... provided with a focus on history, developments, trends ... between the international and Chinese situation is also ...
(Date:9/23/2014)... de Reuil, France (PRWEB) September 23, 2014 ... to protection of laboratory personnel since 1968 and Burdinola, ... the development of a new filtered fume hood. ... above their laboratory fume hood, Burdinola will now offer ... for filtering a wide range of chemicals, best-in-class detection ...
Breaking Biology Technology:Global Bioactive Material Market 2014-2018 2Worcester Polytechnic Institute's Biomanufacturing Expertise to be Featured in Berlin 2Worcester Polytechnic Institute's Biomanufacturing Expertise to be Featured in Berlin 3Phenolic Resin Industry (International, China) Development Policy and Plan Now Available at ReportsnReports.com 2Erlab Partners with Burdinola to Deliver an Innovative Filtered Fume Hood 2
... , RESTON, Va., July 9 Mirixa Corporation, the ... the hiring of three new members to its growing ... FASCP, Kim Swiger, RPh, and Paul Miller, MS, RPh. ... closely with Mirixa,s pharmacy partners, state and national pharmacy ...
... FRANCISCO, Calif., July 9 Poniard Pharmaceuticals, Inc. (Nasdaq: ... therapies, today announced the appointment of Gary A. Lyons, to ... number of directors on the Poniard board to ten. , ... to help guide us as we move toward our goal ...
... , SUNNYVALE, Calif., July 9 Cepheid (Nasdaq: CPHD ... second quarter ended June 30, 2009, on Thursday, July 30, 2009, ... will host a management presentation at 2 p.m. Pacific Time on ... the live webcast, please visit Cepheid,s website at www.cepheid.com/investors ...
Cached Biology Technology:Mirixa Corporation Announces Key New Hires 2Poniard Pharmaceuticals Appoints Gary A. Lyons to Board of Directors 2Poniard Pharmaceuticals Appoints Gary A. Lyons to Board of Directors 3Cepheid Schedules 2009 Second Quarter Financial Results Announcement and Webcast 2
(Date:9/23/2014)... Scientists have scoured cow rumens and termite guts for ... for the production of next-generation biofuels, but some of ... human lower intestine, researchers report. , Their study ... Academy of Sciences , is the first to use ... the human gut can digest fiber, breaking it down ...
(Date:9/23/2014)... could be as good for your mental as your ... by the University of Warwick,s Medical School using data ... BMJ Open focused on mental wellbeing and ... associated with an individual,s fruit and vegetable consumption. , ... or more portions of fruit and vegetables a day, ...
(Date:9/23/2014)... organisms, including humans, have parasitic DNA fragments called "jumping ... instructions in the process. And that phenomenon can result ... the University of Rochester now report that the "jumping ... when a multi-function protein stops keeping them in check ... In a study published today in Nature Communications ...
Breaking Biology News(10 mins):Search for better biofuels microbes leads to the human gut 2Search for better biofuels microbes leads to the human gut 3Eating five a day may keep the blues away 2A multi-function protein is key to stopping genomic parasites from 'jumping' 2
... replacement surgeries can help relieve joint pain common ... the debris from prosthetic joints leads to aseptic ... a Wayne State University researcher determined that the ... disintegration. There was one caveat, however: there are ...
... female mosquito cannot tell if the male that she has ... her eggs, according to a new study from scientists at ... journal Proceedings of the National Academy of Sciences , ... of malaria by interfering with the mosquitoes, ability to reproduce. ...
... ALAMOS, New Mexico, August 8, 2011A Los Alamos National ... the first time the critical role that an elusive ... aid in treatment of peptic ulcers or acid reflux ... waste into transportation fuels. In a paper appearing ...
Cached Biology News:Wayne State researcher discovers antibiotic useful for localized treatment of bone wear 2Mosquitoes can't spot a spermless mate 2Mosquitoes can't spot a spermless mate 3Researchers use neutrons to spy on the elusive hydronium ion 2
HAMP Immunogen: HAMP (AAH20612, 25 a.a. ~ 85 a.a) full length recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...
... peptide transporter 2 (APT2) ... transporter PSF2) (Peptide supply ... transporter involved in antigen ... Antigen: ...
Raised to arginine vasopressin coupled to bovine thyroglobulin with carbodiimide ....
Chicken polyclonal to HAGH ( Abpromise for all tested applications). Antigen: Synthetic peptide, corresponding to N terminal amino acids 110-260 of Human HAGH. Entrez GeneID: 3029 Swiss ...
Biology Products: